Pricing Log in Create free account

Solid Biosciences Inc. (SLDB) vs WAVE Life Sciences Ltd. (WVE)

Solid Biosciences Inc. and WAVE Life Sciences Ltd. are both Biotechnology companies. Solid Biosciences Inc. and WAVE Life Sciences Ltd. are of similar size ($628.6M and $615.5M). Solid Biosciences Inc. has the higher net margin (0.00% vs −309.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Solid Biosciences Inc. leads on 9 and WAVE Life Sciences Ltd. on 5.

Valuation

Metric SLDB WVE Biotechnology median
P/E n/m n/m 8.50
P/S 70.64 9.74 9.71
P/B 2.12 1.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 37.04 2.23 9.21
Earnings yield (34.54%) (34.94%) (33.15%)
Free cash flow yield (23.62%) (30.34%) (25.50%)

Profitability

Metric SLDB WVE Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (333.36%) 0.00%
Net margin 0.00% (309.73%) 0.00%
Free cash flow margin 0.00% (295.46%) 0.00%
Return on equity (65.50%) (68.31%) (56.36%)
Return on assets (56.83%) (49.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SLDB WVE Biotechnology median
Revenue growth (TTM) — (30.42%) 6.02%
EPS growth (last fiscal year) 34.97% (72.86%) 30.26%
Revenue growth, 5-year CAGR — 16.31% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SLDB WVE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.82 9.99 4.72
Net debt to EBITDA 1.05 2.92 0.96

Dividend

Metric SLDB WVE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SLDB WVE Biotechnology median
Market cap 615.48m 628.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack